Evaxion Biotech A/S EVAX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 02/26/21 EST
6.96quote price arrow down-0.45 (-6.07%)
Volume
31,413
52 week range
6.77 - 10.34

...

Loading . . .

KEY STATS

  • Open7.42
  • Day High7.42
  • Day Low6.95
  • Prev Close7.41
  • 52 Week High10.34
  • 52 Week High Date02/08/21
  • 52 Week Low6.77
  • 52 Week Low Date02/23/21
  • Market Cap133.63M
  • Shares Out19.20M
  • 10 Day Average Volume0.09M
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.59
  • P/E (TTM)-11.78
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-15.54M
  • ROE (MRQ)-
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)0.48%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Evaxion Biotech A/S News

There is no recent news for this security.

Latest EVAX News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Evaxion Biotech A/S is a Denmark-based clinical-stage biotechnology company, which specializes in the development of AI-driven immunotherapies to improve the lives of patients with cancer and infectious diseases. The Company decodes the human immune system to discover and develop immunotherapies to treat cancer and infectious diseases. Based on AI-immunology core technology, Evaxion is developing a pipeline of product candidates. In addition, Evaxion develops portfolio of...
Address
Bredgade 34E, Copenhagen K
Copenhagen
1260
Denmark